An email written on October 16 and obtained by the Newschannel 3 I-Team shows internal worries over a flu vaccine administered by the Battle Creek VA due to particulates being found in the serum.
“Upon inspection, it was determined additional vials had the same issue,” wrote Edward G. Dornoff, Acting Medical Director at the Battle Creek VA Medical Center.
After obtaining the email showing concerns about the vaccines, The I-Team sought answers from the Battle Creek VA about what, if any, concerns those who may have received the vaccine should have.
“Out of an abundance of caution and to ensure patient safety, we returned the flu vaccine to the manufacturer and halted use of the vaccines pending resolution of the issue,” wrote Brian Pegouske, Public Affairs Officer for the Battle Creek VA Medical Center.
“The manufacturer’s quality assurance team examined the vaccines and determined all to be safe, effective, and of proper quality. The facility’s flu-vaccine program resumed Oct. 23,” he added.
The original email showing worry about the vaccines showing particulates indicates that 1000 doses of “unaffected product” was borrowed from the Ann Arbor VA to be used in West Michigan.
The manufacturer of the vaccine, Seqirus, according to the email, was also contacted immediately to inspect the batch of vaccines affected.
The company later determined the vaccines that may have been administered with the particulates were safe.
According to the Center for Disease Control, those administering vaccines are urged to be on the lookout for vaccines with discoloration or particulates, and that such vaccines could be dangerous, depending on the severity of the problem.